Source: Pharmacy Times articles
Cutting-edge insights and expert discussions on multiple myeloma will be presented at the 2025 IMS Annual Meeting in Toronto, shaping future treatment standards.
Recent Content
- Regulation of stress tolerance by CREB1 sustains multiple myeloma cell survival
- (no title)
- (no title)
- (no title)
- (no title)
- (no title)
- (no title)
- (no title)
- Daily pill to stop pancreatic cancer spread granted FDA orphan drug status
- CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy